Hill Publishing Group | contact@hillpublisher.com

Hill Publishing Group

Location:Home / Journals / International Journal of Clinical and Experimental Medicine Research /

DOI:http://dx.doi.org/10.26855/ijcemr.2021.07.022

The Role of Bipolar Radiofrequency (Bprf) as a Mechanism of Bio-Stimulation for the Treatment of Vulvo-Vaginal Laxity: A Novel Approach

Date: July 15,2021 |Hits: 425 Download PDF How to cite this paper

Pablo González Isaza1, Diana Velez Rizo2, Ignacio Garibay3, Ricardo Galvan4,*

1Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, San Jorge University Hospital, Pereira, Colombia. 

2Department of Women Health, Cardioinfantil Foundation, Bogotá, Colombia. 

3Institute of Laser and Pulsed Light of Mexico, Ignacio, Mexico.

4Md Dermatologist, Laser Specialist, Guadalajara, Mexico.

*Corresponding author: Ricardo Galvan

Abstract

Objective: Vaginal laxity is a symptom of pelvic floor dysfunction, often is a poorly defined condition, demand for treatment is increasing every day, there are available alternatives with energy-based devices (EBD) such as laser and radiofrequency. Our aim is to demonstrate the impact of Bipolar Radiofrequency (BPRF) on the pelvic floor for aesthetic and functional indications. Methods: A 12 week prospective evaluation was performed to 15 patients of a primary urogynecology unit that met inclusion criteria. Validated questionaires were used before and after BPRF protocol. Results: important changes in the scores of vulvo vaginal laxity questionnaires and perineometry values after BPRF were found No adverse events from the protocol were reported. Conclusions: BPRF treatment was well tolerated and showed a 3-month safety profile in this pilot study, changes in the scores of validated questionnaires are related to subjective improvement in vaginal tightness, these findings warrant longer follow up, and open a new frontier that can improve quality of life.

References

[1] Pauls RN, Fellner AN DG. (2012). Vaginal laxity: a poorly understood quality of life problem; a survey of physician members of the International Urogynecological Association (IUGA). Int Urogyn J., 2012, 23: 1435-48.

[2] Newman R CP. (2018). Genito Pelvic Vaginal Laxity: Classification, Etiology, Symptomatology, and Treatment Considerations. Curr Sex Heal Rep., 2018, 10: 222-36.

[3] Dietz HP, Stankiewicz M, Atan IK, Ferreira CW SM. (2018). Vaginal laxity:what does this symptom mean? Int Urogyn J., 2018, 29(5): 723-8.

[4] Adam Ostrzenski. (2011). An acquired sensation of wide/smooth vagina: a new classification. Eur J Obs Gynecol Reprod Biol., 2011, 158: 97-100.

[5] Amarenco G, Turmel N, Chesnel C, Mezzadri M, Le Breton F, Charlanes A HC. (2019). Vaginal gas: Review. Prog Urol., 2019, 29(17): 1035-40.

[6] Frawley H, Galea M, Phillips B, Sherburn M BK. (2006). Reliability of pelvic floor muscle strength assessment using different test positions and tools. Neurourol Urodyn, 2006, 25: 236-42.

[7] Heather van Raalte, Vincent Lucente, Vladimir Egorov. (2015). High definition pressure mapping of the pelvic floor muscles during valsalva manever, voluntary muscle contraction and involuntary relaxation. Fem pelv med reconst surg., 2015, 21(5): 149-50.

[8] Pardo JS, Sola VD, Riccia PA, Guiloff EF FO. (2006). Colpoperineoplasty in women with a sensation of a wide vagina. Act Obs Gyn Scan., 2006, 85(9): 1125-7.

[9] Salvatore S, Nappi RE, Parma M, et al. (2015). Sexual function after fractional microablative CO (2) laser in women with vulvovaginal atrophy. Climateric, 2015, 18(2): 219-25.

[10] Filippini M, Del Duca E, Negosanti F, et al. (2017). Fractional CO2 laser: from skin rejuvenation to vulvovaginal reshaping. Photomed Laser Surg., 2017, 35(3): 171-5.

[11] Aimes RT QJ. (1995). Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3 / 4- and 1/4-length fragments. J Biol Chem., 1995, 270: 5872-6.

[12] Qureshi AA, Tenenbaum MM MT. Nonsurgical vulvovaginal rejuvenation with radiofrequency and laser devices: a literature review and comprehensive update for aesthetic surgeons. Aesthet Surg J., 18AD, 38(3): 302-11.

[13] Karcher C SN. (2016). Vaginal rejuvenation using energy-based devices. Int J Wom Dermat., 2016, 2: 85-8.

[14] Millheiser LS, Pauls RN, Herbst SJ CB. (2010). Radiofrequency treatment of vaginal laxity after vaginal delivery: nonsurgical vaginal tightening. J Sex Med., 2010, 7(9): 3088-95.

[15] Leibaschoff G, Izasa PG, Cardona JL, Miklos JR MR. (2016). Transcutaneous temperature controlled radiofrequency (TTCRF) for the treatment of menopausal vaginal/genitourinary symptoms. Surg Technol Int., 2016, 29: 149-59.

[16] Red M. Alinsod. (2016). Temperature controlled radiofrequency for vulvovaginal laxity. Lasers Surg Med., 2016, 48(7): 641-5.

[17] Jeffrey C. Caruth. (2018). Evaluation of the safety and efficacy of a novel radiofrequency device for vaginal treatment. Surg Technol Int., 2018, 32: 145-9.

[18] Lalji S LP. (2017). Evaluation of the safety and efficacy of a monopolar nonablative radiofrequency device for the improvement of vulvovaginal laxity and urinary incontinence. J Cosmet Dermat., 2017, 16: 230-4.

[19] Red M. Alinsod. Transcutaneous temperature controlled radiofrequency for orgasmic dysfunction. Lasers Surg Med.2., 2016, 48: 641-5.

[20] Vicariotto F, DE Seta F, Faoro V RM. (2017). Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety. Minerva Ginecol., 2017, 69: 342-9. 

[21] Sekiguchi Y, Utsugisawa Y AY, et al. (2013). Laxity of the vaginal introitus after childbirth: nonsurgical outpatient procedure for vaginal tissue restoration and improved sexual satisfaction using low-energy radiofrequency thermal therapy. J Womens Heal., 2013, 22: 775-81.

[22] Alinsod RM. (2015). Transcutaneous temperature controlled radiofrequency for atrophic vaginitis and dyspareunia. J Minim Invasive Gynecol., 2015, 22: 226-7.

[23] Kamilos MF BC. (2017). New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency. Einstein, 2017, 15: 445-51.

[24] Preminger BA, Kurtzman JS DE. (2020). A Systematic Review of Nonsurgical Vulvovaginal Restoration Devices: An Evidence-Based Examination of Safety and Efficacy. Plast Reconstr Surg., 2020, 146 (5): 552-64.

[25] Fistonić I, Turina ISB, Fistonić N MI. (2016). Short time efficacy and safety of focused monopolar radiofrequency device for labial laxity improvement-noninvasive labia tissue tightening: A prospective cohort study. Lasers Surg Med., 2016, 48: 254-9.

How to cite this paper

The Role of Bipolar Radiofrequency (Bprf) as a Mechanism of Bio-Stimulation for the Treatment of Vulvo-Vaginal Laxity: A Novel Approach

How to cite this paper: Pablo González Isaza, Diana Velez Rizo, Ignacio Garibay, Ricardo Galvan. (2021) The Role of Bipolar Radiofrequency (Bprf) as a Mechanism of Bio-Stimulation for the Treatment of Vulvo-Vaginal Laxity: A Novel ApproachInternational Journal of Clinical and Experimental Medicine Research5(3), 367-376.

DOI: http://dx.doi.org/10.26855/ijcemr.2021.07.022

Volumes & Issues

Free HPG Newsletters

Add your e-mail address to receive free newsletters from Hill Publishing Group.

Contact us

Hill Publishing Group

8825 53rd Ave

Elmhurst, NY 11373, USA

E-mail: contact@hillpublisher.com

Copyright © 2019 Hill Publishing Group Inc. All Rights Reserved.